Videos

Daniel P. Kus, BS Pharm, RPh, discusses how the growth of drug prices could impact the specialty pharmacy patient experience.

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how pharmacy associations work in collaboration.

Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses how specialty pharmacies can navigate limited distribution networks.

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), describes how pharmacy school curriculums have changed.

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), discusses collaborations with the AACP.

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how pharmacies can become sites for student rotations.

Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at the UIC College of Pharmacy, discusses medication management processes that can improve adherence to specialty therapies.

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how practicing pharmacists can become preceptors.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses actions that can enhance the relationship between manufacturers, payers, providers and patients in specialty pharmacy.

Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), discusses how students can engage with the AACP.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses access to cholesterol-lowering PCSK9 inhibitors and whether the hype regarding the impact of these medications was overblown.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School, discusses the treatment switch from statins to PCSK9 inhibitors in patients with high cholesterol.

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.

Mark A. Vineis, vice president of Specialty Pharmacy of Cardinal Health, discusses how the increased interest of the federal government in escalating drug prices may impact specialty pharmacy.

Paul LeVine, vice president of Analytic Services at TrialCard, discusses how specialty pharmacies can use patient feedback surveys to improve treatment outcomes.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the components of an effective patient management program to optimize adherence.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses the challenges of access to high cost specialty medications.

Eric Peacock, co-found and CEO of MyHealthTeams, discusses specialty pharmacy patient engagement on social media.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of the CSI Specialty Group, discusses difficulties for an independent specialty pharmacy in the current landscape.

Rinku A. Patel, PharmD, RPh, founder and CEO of KloudScript, discusses technological advances on the horizon that may improve specialty pharmacy operations.

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses how specialty pharmacies can optimize the prior authorization process.

Paul LeVine, vice president of Analytic Services at TrialCard, discusses how specialty pharmacies can best utilize data to improve patient outcomes.

Marc O'Connor, chief operating officer of Curant Health, discusses how the Affordable Care Act has impacted specialty pharmacy stakeholders.

Mark Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses the impact of growing copay costs for patients on medication adherence.

Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at UIC College of Pharmacy, discusses how providers can improve patient care through collaboration.

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School Clinical Pharmacy Services, discusses the components of successful medication therapy management.

Carlos Torrado, PharmD, JD, PRS explains the training pharmacists receive with respect to prescriptions for controlled substances.

Carlos Torrado, PharmD, JD, PRS explains how pharmacists should handle prescriptions for controlled substances.

Jacob Gettig, PharmD, assistant dean of the Midwestern University Chicago College of Pharmacy, shares his advice to pharmacy students who are considering a residency program and those who have recently started one.